Respiri Ltd
ASX:RSH
Gross Margin
Respiri Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
AU |
R
|
Respiri Ltd
ASX:RSH
|
96.8m AUD |
100%
|
|
US |
Abbott Laboratories
NYSE:ABT
|
195.2B USD |
56%
|
||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
203.6B USD |
67%
|
||
US |
Boston Scientific Corp
NYSE:BSX
|
142.4B USD |
69%
|
||
US |
Stryker Corp
NYSE:SYK
|
140.1B USD |
64%
|
||
IE |
Medtronic PLC
NYSE:MDT
|
109.8B USD |
65%
|
||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.6B USD |
45%
|
||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.6B EUR |
38%
|
||
US |
Edwards Lifesciences Corp
NYSE:EW
|
42.5B USD |
79%
|
||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
284.9B CNY |
64%
|
||
US |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
39B USD |
41%
|
Respiri Ltd
Glance View
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The firm's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The firm has developed a wheezo, which is an eHealth Saas platform that uses a device and app to measure, record and assist asthma monitoring. Its device and app make up a cloud-based mobile health platform that records wheeze and other clinically relevant symptoms and signs of asthma.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Respiri Ltd's most recent financial statements, the company has Gross Margin of 99.6%.